Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 23, 2024Open Access

Solid Lipid Nanoparticles, an Alternative for the Treatment of Triple-Negative Breast Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

MLMonserrat Llaguno‐MuniveMVMaria Inés Vazquez-LopezPGPatricia Garcı́a-López

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Llaguno‐Munive et al. (2024) studied this question.

synapsesocial.com/papers/68e5f62bb6db64358758a846https://doi.org/10.20944/preprints202407.1829.v1
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Solid Lipid Nanoparticles in Precision Oncology: Mechanistic Design, Manufacturing Innovations, and Translational Perspectives2026
  2. 2Multifunctional Roles of Solid Lipid Nanoparticles in Drug Delivery: AComprehensive Insight2026
  3. 3Advancements in Lipid Nanotechnology for the Treatment of Triple-Negative Breast Cancer: Mechanistic Insights and Future Prospects2026
  4. 4The Role of Liposomal Delivery Systems in the Treatment of Triple Negative Breast Cancer2025
  5. 5Lipid-Based Nanoparticles Fused with Natural Killer Cell Plasma Membrane Proteins for Triple-Negative Breast Cancer Therapy2024 · 7 citations